School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, The State University of New York

about

faculty/staff

visit us

Pharmaceutical Sciences Publications

Pharmaceutical Sciences Faculty Publications
Within the Past 2 Years



Dr. Joseph Balthasar

Chen J, Lu Q, Balthasar JP, Balthasar J; Mathematical modeling of topotecan pharmacokinetics and toxicodynamics in mice. J Pharmacokinet Pharmacodyn; 2007 Dec; 34(6). Journal Article

Garg A, Balthasar JP, Balthasar J; Physiologically-based pharmacokinetic (PBPK) model to predict IgG tissue kinetics in wild-type and FcRn-knockout mice. J Pharmacokinet Pharmacodyn; 2007 Oct; 34(5). Journal Article

Deng R, Balthasar JP, Balthasar J; Pharmacokinetic/pharmacodynamic modeling of IVIG effects in a murine model of immune thrombocytopenia. J Pharm Sci; 2007 Jun; 96(6). Journal Article

Balthasar J, Chen J; Development and characterization of high-affinity anti-topotecan IgG and fab fragments ; 2007 Jun; 6.5.

Deng R, Balthasar JP, Balthasar J; Comparison of the effects of antibody-coated liposomes, IVIG, and anti-RBC immunotherapy in a murine model of passive chronic immune thrombocytopenia. Blood; 2007 Mar; 109(6). Comparative Study

Shin BS, Choi JW, Balthasar JP, Hong DK, Kim JJ, Yoo SD, Balthasar J; Determination of roxatidine in human plasma by liquid chromatography/electrospray mass spectrometry and application to a clinical pharmacokinetic study. Rapid Commun Mass Spectrom; 2007 Jan; 21(3). Journal Article


Dr. Sathy Balu-Iyer

Miclea RD, Varma PR, Peng A, Balu-Iyer SV; Development and characterization of lipidic cochleate containing recombinant factor VIII. Biochim Biophys Acta; 2007 Nov; 1768(11). Journal Article

Ramani K, Miclea RD, Purohit VS, Mager DE, Straubinger RM, Balu-Iyer SV; Phosphatidylserine containing liposomes reduce immunogenicity of recombinant human factor VIII (rFVIII) in a murine model of hemophilia A. J Pharm Sci; 2007 Aug. Journal Article

Miclea RD, Purohit VS, Balu-Iyer SV; O-phospho-L-serine, multi-functional excipient for B domain deleted recombinant factor VIII. AAPS J; 2007 Jun; 9(2). In Vitro

Balu-Iyer SV, Purohit VS, Miclea RD; Formulation and Delivery Issues of Therapeutic Proteins ; 2007 Jun; 6.2.

K Ramani, RD Miclea, P Gaitonde, RM Straubinger, SV Balu-Iyer; Passive Transfer of Polyethyleneglycol to Liposomal-Recombinant Human FVIII Enhances its Efficacy in a Murine Model for Hemophilia A Journal of Pharmaceutical Sciences; 2007 Jan.


Dr. Javier Blanco

Vicente-Serrano J, Caballero ML, Rodríguez-Pérez R, Carretero P, Pérez R, Blanco JG, Juste S, Moneo I; Sensitization to serum albumins in children allergic to cow's milk and epithelia. Pediatr Allergy Immunol; 2007 Sep; 18(6). Journal Article

Lakhman SS, Chen X, Gonzalez-Covarrubias V, Schuetz EG, Blanco JG; Functional characterization of the promoter of human carbonyl reductase 1 (CBR1). Role of XRE elements in mediating the induction of CBR1 by ligands of the aryl hydrocarbon receptor. Mol Pharmacol; 2007 Jun; 72(3). Journal Article

Gonzalez-Covarrubias V, Ghosh D, Lakhman SS, Pendyala L, Blanco JG; A functional genetic polymorphism on human carbonyl reductase 1 (CBR1 V88I) impacts on catalytic activity and NADPH binding affinity. Drug Metab Dispos; 2007 Jun; 35(6). Journal Article

Weiss JR, Baer MR, Ambrosone CB, Blanco JG, Hutson A, Ford LA, Moysich KB; Concordance of pharmacogenetic polymorphisms in tumor and germ line DNA in adult patients with acute myeloid leukemia. Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5). Journal Article


Dr. Kathleen Boje

Page NA, Paganelli M, Boje KM, Fung HL; An interactive lesson in acid/base and pro-drug chemistry using sodium gamma-hydroxybutyrate and commercial test coasters. Am J Pharm Educ; 2007 Jun; 71(3). Journal Article

Raybon JJ, Boje KM; Pharmacokinetics and pharmacodynamics of gamma-hydroxybutyric acid during tolerance in rats: effects on extracellular dopamine. J Pharmacol Exp Ther; 2007 Mar; 320(3). Journal Article

Bhattacharya I, Boje KM; Feasibility of D-glucuronate to enhance gamma-hydroxybutyric acid metabolism during gamma-hydroxybutyric acid toxicity: pharmacokinetic and pharmacodynamic studies. Biopharm Drug Dispos; 2007 Jan; 28(1). Journal Article

Bhattacharya I, Boje KM; Potential gamma-hydroxybutyric acid (GHB) drug interactions through blood-brain barrier transport inhibition: a pharmacokinetic simulation-based evaluation. J Pharmacokinet Pharmacodyn; 2006 Oct; 33(5). Journal Article

Bhattacharya I, Raybon JJ, Boje KM; Alterations in neuronal transport but not blood-brain barrier transport are observed during gamma-hydroxybutyrate (GHB) sedative/hypnotic tolerance. Pharm Res; 2006 Sep; 23(9). In Vitro


Dr. Daniel Brazeau

Tsai WJ, McCormick KM, Brazeau DA, Brazeau GA; Estrogen effects on skeletal muscle insulin-like growth factor 1 and myostatin in ovariectomized rats. Exp Biol Med (Maywood); 2007 Nov; 232(10). Journal Article

Chanda P, Zhang A, Brazeau D, Sucheston L, Freudenheim JL, Ambrosone C, Ramanathan M, Brazeau DA; Information-theoretic metrics for visualizing gene-environment interactions. Am J Hum Genet; 2007 Nov; 81(5). Journal Article

Renzi SE, Krzeminski MA, Sauberan MM, Brazeau DA, Brazeau GA; Prepharmacy years in college and academic performance in a professional program. Am J Pharm Educ; 2007 Aug; 71(4). Comparative Study

Moon YJ, Zhang S, Brazeau DA, Morris ME; Effects of the flavonoid biochanin A on gene expression in primary human hepatocytes and human intestinal cells. Mol Nutr Food Res; 2007 Mar; 51(3). Journal Article

Moon YJ, Brazeau DA, Morris ME; Effects of flavonoids genistein and biochanin a on gene expression and their metabolism in human mammary cells. Nutr Cancer; 2007 Jan; 57(1). Journal Article

Brazeau DA; Pharmacogenomics of Warfarin Therapy for Venous Clinical Laboratories LabQ series; 2007 Jan; 1.

Brazeau DA, Brazeau GA; A required course in human genomics, pharmacogenomics, and bioinformatics. Am J Pharm Educ; 2006 Dec; 70(6). Journal Article

Bhasi K, Zhang L, Brazeau D, Zhang A, Ramanathan M; Information-theoretic identification of predictive SNPs and supervised visualization of genome-wide association studies. Nucleic Acids Res; 2006 Aug; 34(14). Evaluation Studies


Dr. Gayle Brazeau

Tsai WJ, McCormick KM, Brazeau DA, Brazeau GA; Estrogen effects on skeletal muscle insulin-like growth factor 1 and myostatin in ovariectomized rats. Exp Biol Med (Maywood); 2007 Nov; 232(10). Journal Article

Kranz H, Yilmaz E, Brazeau GAYLE, Bodmeier R; In Vitro and In Vivo Drug Release from a Novel In Situ Forming Drug Delivery System. Pharm Res; 2007 Oct. Journal Article

Rungseevijitprapa W, Brazeau GA, Simkins JW, Bodmeier R; Myotoxicity studies of O/W-in situ forming microparticle systems. Eur J Pharm Biopharm; 2007 Oct. Journal Article

Smesny AL, Williams JS, Brazeau GA, Weber RJ, Matthews HW, Das SK; Barriers to scholarship in dentistry, medicine, nursing, and pharmacy practice faculty. Am J Pharm Educ; 2007 Oct; 71(5). Journal Article

Renzi SE, Krzeminski MA, Sauberan MM, Brazeau DA, Brazeau GA; Prepharmacy years in college and academic performance in a professional program. Am J Pharm Educ; 2007 Aug; 71(4). Comparative Study

Brazeau GA; Teaching, practice and technology. Am J Pharm Educ; 2007 Jun; 71(3). Journal Article

Brazeau DA; Pharmacogenomics of Warfarin Therapy for Venous Clinical Laboratories LabQ series; 2007 Jan; 1.

Brazeau DA, Brazeau GA; A required course in human genomics, pharmacogenomics, and bioinformatics. Am J Pharm Educ; 2006 Dec; 70(6). Journal Article

Brazeau GA, Van Tyle JH; Sabbaticals: the key to sharpening our professional skills as educators, scientists, and clinicians. Am J Pharm Educ; 2006 Oct; 70(5). Journal Article


Dr. Walter Conway

Conway WD; Service life of counter-current chromatography coils. J Chromatogr A; 2007 Jun; 1151(1-2). Journal Article


Dr. Debra Dubois

Hazra A, Pyszczynski N, DuBois DC, Almon RR, Jusko WJ; Modeling receptor/gene-mediated effects of corticosteroids on hepatic tyrosine aminotransferase dynamics in rats: dual regulation by endogenous and exogenous corticosteroids. J Pharmacokinet Pharmacodyn; 2007 Oct; 34(5). Journal Article

Yao Z, Dubois DC, Almon RR, Jusko WJ; Pharmacokinetic/pharmacodynamic modeling of corticosterone suppression and lymphocytopenia by methylprednisolone in rats. J Pharm Sci; 2007 Sep. Journal Article

Hazra A, Pyszczynski N, DuBois DC, Almon RR, Jusko WJ; Pharmacokinetics of methylprednisolone after intravenous and intramuscular administration in rats. Biopharm Drug Dispos; 2007 Sep; 28(6). Journal Article

Almon RR, DuBois DC, Yao Z, Hoffman EP, Ghimbovschi S, Jusko WJ; Microarray analysis of the temporal response of skeletal muscle to methylprednisolone: comparative analysis of two dosing regimens. Physiol Genomics; 2007 Aug; 30(3). Comparative Study

Yang E, Simcha D, Almon RR, Dubois DC, Jusko WJ, Androulakis IP; Context specific transcription factor prediction. Ann Biomed Eng; 2007 Jun; 35(6). Journal Article

Hazra A, DuBois DC, Almon RR, Jusko WJ; Assessing the dynamics of nuclear glucocorticoid-receptor complex: adding flexibility to gene expression modeling. J Pharmacokinet Pharmacodyn; 2007 Jun; 34(3). Journal Article

Almon RR, DuBois DC, Jusko WJ; A microarray analysis of the temporal response of liver to methylprednisolone: a comparative analysis of two dosing regimens. Endocrinology; 2007 May; 148(5). Comparative Study

Yao Z, Zhao B, Hoffman EP, Ghimbovschi S, DuBois DC, Almon RR, Jusko WJ; Application of scaling factors in simultaneous modeling of microarray data from diverse chips. Pharm Res; 2007 Apr; 24(4). Comparative Study


Ms. Jill Fiedler-Kelly

No Recent Publications
 

Dr. Ho Leung Fung

Turowski SG, Jank KE, Fung HL, Fung H; Inactivation of hepatic enzymes by inhalant nitrite--in vivo and in vitro studies. AAPS J; 2007 Jul; 9(3). Journal Article

Fung HL, Tran DC, Fung H; Effects of inhalant nitrites on VEGF expression: a feasible link to Kaposi's sarcoma? J Neuroimmune Pharmacol; 2006 Sep; 1(3). Journal Article


Dr. Wenqing Gao

Gao W, Dalton JT; Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs). Drug Discov Today; 2007 Mar; 12(5-6). Journal Article

Kearbey JD, Gao W, Narayanan R, Fisher SJ, Wu D, Miller DD, Dalton JT; Selective Androgen Receptor Modulator (SARM) treatment prevents bone loss and reduces body fat in ovariectomized rats. Pharm Res; 2007 Feb; 24(2). Journal Article

Gao W, Dalton JT; Ockham's razor and selective androgen receptor modulators (SARMs): are we overlooking the role of 5alpha-reductase? Mol Interv; 2007 Feb; 7(1). Journal Article

Gao W, Kim J, Dalton JT; Pharmacokinetics and pharmacodynamics of nonsteroidal androgen receptor ligands. Pharm Res; 2006 Aug; 23(8). Journal Article


Dr. William Jusko

Woo S, Krzyzanski W, Duliege AM, Stead RB, Jusko WJ; Population Pharmacokinetics and Pharmacodynamics of Peptidic Erythropoiesis Receptor Agonist (ERA) in Healthy Volunteers. J Clin Pharmacol; 2008 Jan; 48(1). Journal Article

Woo S, Krzyzanski W, Jusko WJ; Target-mediated pharmacokinetic and pharmacodynamic model of recombinant human erythropoietin (rHuEPO). J Pharmacokinet Pharmacodyn; 2007 Dec; 34(6). Journal Article

Woo S, Krzyzanski W, Duliege AM, Stead RB, Jusko WJ; Population Pharmacokinetics and Pharmacodynamics of Peptidic Erythropoiesis Receptor Agonist (ERA) in Healthy Volunteers. J Clin Pharmacol; 2007 Nov. Journal Article

Hazra A, Pyszczynski N, DuBois DC, Almon RR, Jusko WJ; Modeling receptor/gene-mediated effects of corticosteroids on hepatic tyrosine aminotransferase dynamics in rats: dual regulation by endogenous and exogenous corticosteroids. J Pharmacokinet Pharmacodyn; 2007 Oct; 34(5). Journal Article

Yao Z, Dubois DC, Almon RR, Jusko WJ; Pharmacokinetic/pharmacodynamic modeling of corticosterone suppression and lymphocytopenia by methylprednisolone in rats. J Pharm Sci; 2007 Sep. Journal Article

Hazra A, Pyszczynski N, DuBois DC, Almon RR, Jusko WJ; Pharmacokinetics of methylprednisolone after intravenous and intramuscular administration in rats. Biopharm Drug Dispos; 2007 Sep; 28(6). Journal Article

Woo S, Jusko WJ; Interspecies comparisons of pharmacokinetics and pharmacodynamics of recombinant human erythropoietin. Drug Metab Dispos; 2007 Sep; 35(9). Journal Article

Almon RR, DuBois DC, Yao Z, Hoffman EP, Ghimbovschi S, Jusko WJ; Microarray analysis of the temporal response of skeletal muscle to methylprednisolone: comparative analysis of two dosing regimens. Physiol Genomics; 2007 Aug; 30(3). Comparative Study

Yang E, Simcha D, Almon RR, Dubois DC, Jusko WJ, Androulakis IP; Context specific transcription factor prediction. Ann Biomed Eng; 2007 Jun; 35(6). Journal Article

Hazra A, DuBois DC, Almon RR, Jusko WJ; Assessing the dynamics of nuclear glucocorticoid-receptor complex: adding flexibility to gene expression modeling. J Pharmacokinet Pharmacodyn; 2007 Jun; 34(3). Journal Article

Samtani MN, Jusko WJ; Quantification of dexamethasone and corticosterone in rat biofluids and fetal tissue using highly sensitive analytical methods: assay validation and application to a pharmacokinetic study. Biomed Chromatogr; 2007 Jun; 21(6). Evaluation Studies

Hong Y, Mager DE, Blum RA, Jusko WJ; Population pharmacokinetic/pharmacodynamic modeling of systemic corticosteroid inhibition of whole blood lymphocytes: modeling interoccasion pharmacodynamic variability. Pharm Res; 2007 Jun; 24(6). Journal Article

Almon RR, DuBois DC, Jusko WJ; A microarray analysis of the temporal response of liver to methylprednisolone: a comparative analysis of two dosing regimens. Endocrinology; 2007 May; 148(5). Comparative Study

Yao Z, Zhao B, Hoffman EP, Ghimbovschi S, DuBois DC, Almon RR, Jusko WJ; Application of scaling factors in simultaneous modeling of microarray data from diverse chips. Pharm Res; 2007 Apr; 24(4). Comparative Study

Wetzler M, Earp JC, Brady MT, Keng MK, Jusko WJ; Synergism between arsenic trioxide and heat shock protein 90 inhibitors on signal transducer and activator of transcription protein 3 activity--pharmacodynamic drug-drug interaction modeling. Clin Cancer Res; 2007 Apr; 13(7). Journal Article

Mager DE, Jusko WJ; Mechanistic pharmacokinetic/pharmacodynamic models II. ; 2007 Mar; 23.

Jin JY, Jusko WJ; Pharmacogenomics and Pharmacokinetic/Pharmacodynamic Modeling ; 2007 Mar; 19.

Hazra A, Krzyzanski W, Jusko WJ; Mathematical assessment of properties of precursor-dependent indirect pharmacodynamic response models. J Pharmacokinet Pharmacodyn; 2006 Dec; 33(6). Journal Article

Woo S, Krzyzanski W, Jusko WJ; Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after intravenous and subcutaneous administration in rats. J Pharmacol Exp Ther; 2006 Dec; 319(3). Journal Article

Krzyzanski W, Dmochowski J, Matsushima N, Jusko WJ; Assessment of dosing impact on intra-individual variability in estimation of parameters for basic indirect response models. J Pharmacokinet Pharmacodyn; 2006 Oct; 33(5). Journal Article

Meno-Tetang GM, Li H, Mis S, Pyszczynski N, Heining P, Lowe P, Jusko WJ; Physiologically based pharmacokinetic modeling of FTY720 (2-amino-2[2-(-4-octylphenyl)ethyl]propane-1,3-diol hydrochloride) in rats after oral and intravenous doses. Drug Metab Dispos; 2006 Sep; 34(9). Journal Article

Schwab M, Coksaygan T, Samtani MN, Jusko WJ, Nathanielsz PW; Kinetics of betamethasone and fetal cardiovascular adverse effects in pregnant sheep after different doses. Obstet Gynecol; 2006 Sep; 108(3 Pt). Comparative Study


Dr. Thomas Kalman

No Recent Publications
 

Dr. Wojciech Krzyzanski

Woo S, Krzyzanski W, Duliege AM, Stead RB, Jusko WJ; Population Pharmacokinetics and Pharmacodynamics of Peptidic Erythropoiesis Receptor Agonist (ERA) in Healthy Volunteers. J Clin Pharmacol; 2008 Jan; 48(1). Journal Article

Krzyzanski W, Wyska E; Pharmacokinetics and pharmacodynamics of erythropoietin receptor in healthy volunteers. Naunyn Schmiedebergs Arch Pharmacol; 2007 Dec. Journal Article

Woo S, Krzyzanski W, Jusko WJ; Target-mediated pharmacokinetic and pharmacodynamic model of recombinant human erythropoietin (rHuEPO). J Pharmacokinet Pharmacodyn; 2007 Dec; 34(6). Journal Article

Woo S, Krzyzanski W, Duliege AM, Stead RB, Jusko WJ; Population Pharmacokinetics and Pharmacodynamics of Peptidic Erythropoiesis Receptor Agonist (ERA) in Healthy Volunteers. J Clin Pharmacol; 2007 Nov. Journal Article

Woo S, Krzyzanski W, Jusko WILLIAM; Pharmacodynamic model for chemotherapy-induced anemia in rats. Cancer Chemother Pharmacol; 2007 Sep. Journal Article

Krzyzanski W, Bell J; Modelling the geometric features and investigating electrical properties of dendrites in a fish thalamic neuron. Math Med Biol; 2007 Sep; 24(3). Journal Article

Krzyzanski W, Oberdoester J, Rabin RA; Mechanism of ethanol enhancement of apoptosis and caspase activation in serum-deprived PC12 cells. Life Sci; 2007 Aug; 81(9). Journal Article

Wiczling P, Krzyzanski W; Method of determination of the reticulocyte age distribution from flow cytometry count by a structured-population model. Cytometry A; 2007 Jul; 71(7). Evaluation Studies

Abraham AK, Krzyzanski W, Mager DE; Partial derivative-based sensitivity analysis of models describing target-mediated drug disposition. AAPS J; 2007 Jun; 9(2). Journal Article

Straubinger RM, Krzyzanski W, Francoforte CM, Qu J; Applications of quantitative pharmacodynamic effect markers in drug target identification and therapy development. Anticancer Res; 2007 May; 27(3A). Journal Article

Krzyzanski W, Perez-Ruixo JJ; An assessment of recombinant human erythropoietin effect on reticulocyte production rate and lifespan distribution in healthy subjects. Pharm Res; 2007 Apr; 24(4). Journal Article

Hazra A, Krzyzanski W, Jusko WJ; Mathematical assessment of properties of precursor-dependent indirect pharmacodynamic response models. J Pharmacokinet Pharmacodyn; 2006 Dec; 33(6). Journal Article

Woo S, Krzyzanski W, Jusko WJ; Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after intravenous and subcutaneous administration in rats. J Pharmacol Exp Ther; 2006 Dec; 319(3). Journal Article

Krzyzanski W, Dmochowski J, Matsushima N, Jusko WJ; Assessment of dosing impact on intra-individual variability in estimation of parameters for basic indirect response models. J Pharmacokinet Pharmacodyn; 2006 Oct; 33(5). Journal Article


Dr. Sukwinder Lakhman

No Recent Publications
 

Dr. Gerhard Levy

No Recent Publications
 

Dr. Donald Mager

Gengo FM, Rubin L, Robson M, Rainka M, Gengo MF, Mager DE, Bates V; Effects of Ibuprofen on the Magnitude and Duration of Aspirin's Inhibition of Platelet Aggregation: Clinical Consequences in Stroke Prophylaxis. J Clin Pharmacol; 2008 Jan; 48(1). Journal Article

Siluk D, Mager DE, Gronich N, Abernethy D, Wainer IW; HPLC-atmospheric pressure chemical ionization mass spectrometric method for enantioselective determination of R,S-propranolol and R,S-hyoscyamine in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Nov; 859(2). Journal Article

Mager DE, Kobrinsky E, Masoudieh A, Maltsev A, Abernethy DR, Soldatov NM; Analysis of functional signaling domains from fluorescence imaging and the two-dimensional continuous wavelet transform. Biophys J; 2007 Oct; 93(8). Journal Article

Cao YJ, Mager DE, Simonsick EM, Hilmer SN, Ling SM, Windham BG, Crentsil V, Yasar S, Fried LP, Abernethy DR; Physical and Cognitive Performance and Burden of Anticholinergics, Sedatives, and ACE Inhibitors in Older Women. Clin Pharmacol Ther; 2007 Aug. Journal Article

Ramani K, Miclea RD, Purohit VS, Mager DE, Straubinger RM, Balu-Iyer SV; Phosphatidylserine containing liposomes reduce immunogenicity of recombinant human factor VIII (rFVIII) in a murine model of hemophilia A. J Pharm Sci; 2007 Aug. Journal Article

Abraham AK, Krzyzanski W, Mager DE; Partial derivative-based sensitivity analysis of models describing target-mediated drug disposition. AAPS J; 2007 Jun; 9(2). Journal Article

Hong Y, Mager DE, Blum RA, Jusko WJ; Population pharmacokinetic/pharmacodynamic modeling of systemic corticosteroid inhibition of whole blood lymphocytes: modeling interoccasion pharmacodynamic variability. Pharm Res; 2007 Jun; 24(6). Journal Article

Mager DE, Abernethy DR; Use of wavelet and fast Fourier transforms in pharmacodynamics. J Pharmacol Exp Ther; 2007 May; 321(2). Journal Article

Hilmer SN, Mager DE, Simonsick EM, Cao Y, Ling SM, Windham BG, Harris TB, Hanlon JT, Rubin SM, Shorr RI, Bauer DC, Abernethy DR; A drug burden index to define the functional burden of medications in older people. Arch Intern Med; 2007 Apr; 167(8). Journal Article

Mager DE, Jusko WJ; Mechanistic pharmacokinetic/pharmacodynamic models II. ; 2007 Mar; 23.

O'Connor R, O'Leary M, Ballot J, Collins CD, Kinsella P, Mager DE, Arnold RD, O'Driscoll L, Larkin A, Kennedy S, Fennelly D, Clynes M, Crown J; A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer. Cancer Chemother Pharmacol; 2007 Jan; 59(1). Clinical Trial, Phase I

Mager DE; Quantitative structure-pharmacokinetic/pharmacodynamic relationships. Adv Drug Deliv Rev; 2006 Nov; 58(12-13). Journal Article


Dr. Marilyn Morris

Wang Q, Lu Y, Morris ME; Monocarboxylate transporter (MCT) mediates the transport of gamma-hydroxybutyrate in human kidney HK-2 cells. Pharm Res; 2007 Jun; 24(6). Journal Article

Wang Q, Morris ME; The role of monocarboxylate transporter 2 and 4 in the transport of gamma-hydroxybutyric acid in mammalian cells. Drug Metab Dispos; 2007 May; 35(8). Journal Article

Moon YJ, Zhang S, Brazeau DA, Morris ME; Effects of the flavonoid biochanin A on gene expression in primary human hepatocytes and human intestinal cells. Mol Nutr Food Res; 2007 Mar; 51(3). Journal Article

Wang X, Morris ME; Effects of the flavonoid chrysin on nitrofurantoin pharmacokinetics in rats: potential involvement of ABCG2. Drug Metab Dispos; 2007 Feb; 35(2). Journal Article

Wang Q, Morris ME; Flavonoids modulate monocarboxylate transporter-1-mediated transport of gamma-hydroxybutyrate in vitro and in vivo. Drug Metab Dispos; 2007 Feb; 35(2). Journal Article

Moon YJ, Brazeau DA, Morris ME; Effects of flavonoids genistein and biochanin a on gene expression and their metabolism in human mammary cells. Nutr Cancer; 2007 Jan; 57(1). Journal Article

Wang Q, Lu Y, Yuan M, Darling IM, Repasky EA, Morris ME; Characterization of monocarboxylate transport in human kidney HK-2 cells. Mol Pharm; 2006 Nov; 3(6). Comparative Study

Morris ME; Flavonoid-drug interactions: effects of flavonoids on ABC transporters. Proceedings of the 11th Shizuoka Forum on Health and Longevity; 2006 Oct.

Wang Q, Darling IM, Morris ME; Transport of gamma-hydroxybutyrate in rat kidney membrane vesicles: Role of monocarboxylate transporters. J Pharmacol Exp Ther; 2006 Aug; 318(2). In Vitro

Moon YJ, Sagawa K, Frederick K, Zhang S, Morris ME; Pharmacokinetics and bioavailability of the isoflavone biochanin A in rats. AAPS J; 2006 Jul; 8(3). Journal Article


Dr. Jun Qu

Drake EJ, Cao J, Qu J, Shah MB, Straubinger RM, Gulick AM; The 1.8 A crystal structure of PA2412, an MbtH-like protein from the pyoverdine cluster of Pseudomonas aeruginosa. J Biol Chem; 2007 Jul; 282(28). Journal Article

Qu J, Qu Y, Straubinger RM; Ultra-sensitive quantification of corticosteroids in plasma samples using selective solid-phase extraction and reversed-phase capillary high-performance liquid chromatography/tandem mass spectrometry. Anal Chem; 2007 May; 79(10). Journal Article

Straubinger RM, Krzyzanski W, Francoforte CM, Qu J; Applications of quantitative pharmacodynamic effect markers in drug target identification and therapy development. Anticancer Res; 2007 May; 27(3A). Journal Article

Straubinger RM, Qu J; Proteomic approaches to the quantification of pharmacodynamic effect markers: General applications in drug target and biomarker identification ANTICANCER RESEARCH; 2007 May; 27(3A).


Dr. Murali Ramanathan

Chanda P, Zhang A, Brazeau D, Sucheston L, Freudenheim JL, Ambrosone C, Ramanathan M, Brazeau DA; Information-theoretic metrics for visualizing gene-environment interactions. Am J Hum Genet; 2007 Nov; 81(5). Journal Article

Garg N, Weinstock-Guttman B, Bhasi K, Locke J, Ramanathan M; An association between autoreactive antibodies and anti-interferon-beta antibodies in multiple sclerosis. Mult Scler; 2007 Aug; 13(7). Journal Article

Garg N, Zivadinov R, Ramanathan M, Vasiliu I, Locke J, Watts K, Lema J, Rajeswary J, Munschauer FE, Ambrus J, Weinstock-Guttman B; Clinical and MRI correlates of autoreactive antibodies in multiple sclerosis patients. J Neuroimmunol; 2007 Jul; 187(1-2). Journal Article

Weinstock-Guttman B, Tamaño-Blanco M, Bhasi K, Zivadinov R, Ramanathan M; Pharmacogenetics of MXA SNPs in interferon-beta treated multiple sclerosis patients. J Neuroimmunol; 2007 Jan; 182(1-2). Journal Article

Hwang W, Cho YR, Zhang A, Ramanathan M; A novel functional module detection algorithm for protein-protein interaction networks. Algorithms Mol Biol; 2006 Dec; 1. Journal Article

Chadha K, Weinstock-Guttman B, Zivadinov R, Bhasi K, Muhitch J, Feichter J, Tamaño-Blanco M, Abdelrahman N, Ambrus J, Munschauer F, Ramanathan M; Interferon inhibitory activity in patients with multiple sclerosis. Arch Neurol; 2006 Nov; 63(11). Comparative Study

Weinstock-Guttman B, Hong J, Santos R, Tamaño-Blanco M, Badgett D, Patrick K, Baier M, Feichter J, Gallagher E, Garg N, Ramanathan M; Interferon-beta modulates bone-associated cytokines and osteoclast precursor activity in multiple sclerosis patients. Mult Scler; 2006 Oct; 12(5). Comparative Study

Bhasi K, Zhang L, Brazeau D, Zhang A, Ramanathan M; Information-theoretic identification of predictive SNPs and supervised visualization of genome-wide association studies. Nucleic Acids Res; 2006 Aug; 34(14). Evaluation Studies

Hwang W, Cho Y, Zhang A, and Murali Ramanathan; Signal transduction model based functional module detection algorithm for protein-protein interaction networks ; 2006 Aug. Abstract

Cho Y, Hwang W, Zhang A and Murali Ramanathan; Assessing hierarchical modularity in protein interaction networks ; 2006 Aug. Abstract


Dr. Jerome Schentag

Noskin GA, Rubin RJ, Schentag JJ, Kluytmans J, Hedblom EC, Jacobson C, Smulders M, Gemmen E, Bharmal M; National trends in Staphylococcus aureus infection rates: impact on economic burden and mortality over a 6-year period (1998-2003). Clin Infect Dis; 2007 Nov; 45(9). Journal Article

Iannini PB, Paladino JA, Lavin B, Singer ME, Schentag JJ; A case series of macrolide treatment failures in community acquired pneumonia. J Chemother; 2007 Oct; 19(5). Journal Article

Kiem S, Schentag JJ; Interpretation of antibiotic concentration ratios measured in epithelial lining fluid. Antimicrob Agents Chemother; 2007 Sep. Journal Article

Schentag JJ, Klugman KP, Yu VL, Adelman MH, Wilton GJ, Chiou CC, Patel M, Lavin B, Paladino JA; Streptococcus pneumoniae bacteraemia: pharmacodynamic correlations with outcome and macrolide resistance--a controlled study. Int J Antimicrob Agents; 2007 Sep; 30(3). Journal Article

Paladino JA, Sunderlin JL, Adelman MH, Singer ME, Schentag JJ; Observations on vancomycin use in U.S. hospitals. Am J Health Syst Pharm; 2007 Aug; 64(15). Journal Article

Moise PA, Sakoulas G, Forrest A, Schentag JJ; Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob Agents Chemother; 2007 Jul; 51(7). In Vitro

Schentag JJ, Hill G, Chu T, Rayner CR; Similarity in pharmacokinetics of oseltamivir and oseltamivir carboxylate in Japanese and Caucasian subjects. J Clin Pharmacol; 2007 Jun; 47(6). Comparative Study

Paladino JA, Eubanks DA, Adelman MH, Schentag JJ; Once-daily cefepime versus ceftriaxone for nursing home-acquired pneumonia. J Am Geriatr Soc; 2007 May; 55(5). Comparative Study

Paladino JA, Adelman MH, Schentag JJ, Iannini PB; Direct costs in patients hospitalised with community-acquired pneumonia after non-response to outpatient treatment with macrolide antibacterials in the US. Pharmacoeconomics; 2007 Jan; 25(8). Journal Article

LeBlanc JM, Dasta JF, Pruchnicki MC, Schentag JJ; Impact of disease states on the pharmacokinetics and pharmacodynamics of angiotensin-converting enzyme inhibitors. J Clin Pharmacol; 2006 Sep; 46(9). Journal Article


Mr. David Soda

No Recent Publications
 

Dr. Robert Straubinger

Ramani K, Miclea RD, Purohit VS, Mager DE, Straubinger RM, Balu-Iyer SV; Phosphatidylserine containing liposomes reduce immunogenicity of recombinant human factor VIII (rFVIII) in a murine model of hemophilia A. J Pharm Sci; 2007 Aug. Journal Article

Drake EJ, Cao J, Qu J, Shah MB, Straubinger RM, Gulick AM; The 1.8 A crystal structure of PA2412, an MbtH-like protein from the pyoverdine cluster of Pseudomonas aeruginosa. J Biol Chem; 2007 Jul; 282(28). Journal Article

Qu J, Qu Y, Straubinger RM; Ultra-sensitive quantification of corticosteroids in plasma samples using selective solid-phase extraction and reversed-phase capillary high-performance liquid chromatography/tandem mass spectrometry. Anal Chem; 2007 May; 79(10). Journal Article

Straubinger RM, Krzyzanski W, Francoforte CM, Qu J; Applications of quantitative pharmacodynamic effect markers in drug target identification and therapy development. Anticancer Res; 2007 May; 27(3A). Journal Article

Straubinger RM, Qu J; Proteomic approaches to the quantification of pharmacodynamic effect markers: General applications in drug target and biomarker identification ANTICANCER RESEARCH; 2007 May; 27(3A).

K Ramani, RD Miclea, P Gaitonde, RM Straubinger, SV Balu-Iyer; Passive Transfer of Polyethyleneglycol to Liposomal-Recombinant Human FVIII Enhances its Efficacy in a Murine Model for Hemophilia A Journal of Pharmaceutical Sciences; 2007 Jan.


Dr. Kenneth Tramposch

No Recent Publications
 

Dr, David Triggle

No Recent Publications
 

Dr. Aiming Yu

Felmlee MA, Lon HK, Gonzalez FJ, Yu AM; Cytochrome P450 expression and regulation in CYP3A4/CYP2D6 double transgenic humanized mice. Drug Metab Dispos; 2007 Nov. Journal Article

Yu AM; Small interfering RNA in drug metabolism and transport. Curr Drug Metab; 2007 Oct; 8(7). Journal Article

  Faces & Stories 

We interviewed students, faculty, and alumni—here's what they had to say.

» Learn more

privacy policy | contact us | visit us | pharmacy home | UB home